Literature DB >> 26223723

Malignant Otitis Externa - A Retrospective Study of 15 Patients Treated in a Tertiary Healthcare Center.

Vadisha Bhat1, Ajaz Aziz, Satheesh Kumar Bhandary, Rajeshwary Aroor, Shrinath D Kamath P, Marina Saldanha.   

Abstract

OBJECTIVE: Malignant otitis externa (MOE) is an uncommon but potentially fatal disease of the external auditory canal. The study aimed at evaluating the demographic profile, coexisting disabilities, clinical presentations, and management of MOE.
MATERIALS AND METHODS: This is a retrospective study of patients with MOE who were treated at the Otorhinolaryngology Department of our institution. The case records of patients treated between 2006 and 2013 for MOE were reviewed from the Medical Records Department of the hospital. The details were tabulated in a master chart, and the data were analyzed.
RESULTS: Fifteen patients with MOE were treated as inpatients at the Otorhinolaryngology Department of our hospital during the study period. Of these, 12 were males and three were females. Among the 15 patients, 14 were diabetic and one was non-diabetic. Earache was the most common symptom observed in all patients; edema and granulations in the ear canal was the most common sign observed in 12 patients. Pseudomonas aeruginosa was isolated in 11 patients. All patients were managed medically with intravenous antibiotics.
CONCLUSION: MOE is a rare but aggressive condition affecting the external ear, which is commonly observed in elderly diabetic individuals. Immune senescence may be the cause of MOE in elderly people. Pseudomonas is the most common causative organism isolated in this condition. Most of these patients can be managed with medical treatment; reserving surgery only for the removal of granulation tissue and for histopathological examination.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223723     DOI: 10.5152/iao.2015.430

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  8 in total

1.  Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre.

Authors:  Carla Espiney Amaro; Raquel Espiney; Lucian Radu; Francisco Guerreiro
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-04       Impact factor: 2.503

2.  Extensive Skull Base Osteomyelitis Secondary to Malignant Otitis Externa.

Authors:  Luca Bruschini; Stefano Berrettini; Cambi Christina; Simone Ferranti; Silvia Fabiani; Marina Cavezza; Francesca Forli; Amelia Santoro; Enrico Tagliaferri
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

3.  Malignant Otitis Externa: Causes for Various Treatment Responses.

Authors:  Nenad Arsovic; Nemanja Radivojevic; Snezana Jesic; Snezana Babac; Ljiljana Cvorovic; Zoran Dudvarski
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

4.  Malignant Otitis Externa: A Retrospective Analysis and Treatment Outcomes.

Authors:  İsa Kaya; Baha Sezgin; Sevinç Eraslan; Kerem Öztürk; Sercan Göde; Cem Bilgen; Tayfun Kirazlı
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

5.  A retrospective review of 14 cases of malignant otitis externa.

Authors:  Saldanha Marina; M K Goutham; A Rajeshwary; Bhat Vadisha; T Devika
Journal:  J Otol       Date:  2019-01-08

Review 6.  Necrotising Otitis Externa: A Review of Imaging Modalities.

Authors:  Hammaad A Khan
Journal:  Cureus       Date:  2021-12-25

7.  Characteristics, management and outcome of a large necrotising otitis externa case series: need for standardised case definition.

Authors:  S H Hodgson; V J Sinclair; J Arwyn-Jones; K Oh; K Nucken; M Perenyei; V Sivapathasingam; P Martinez-Devesa; S T Pendlebury; J D Ramsden; P C Matthews; P Pretorius; M I Andersson
Journal:  J Laryngol Otol       Date:  2022-01-19       Impact factor: 2.187

Review 8.  Malignant Otitis External: Our Experience and Literature Review.

Authors:  Antonella M Di Lullo; Camilla Russo; Piera Piroli; Alessandra Petti; Pasquale Capriglione; Elena Cantone; Gaetano Motta; Maurizio Iengo; Andrea Elefante; Michele Cavaliere
Journal:  Am J Case Rep       Date:  2020-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.